Zobrazeno 1 - 10
of 41
pro vyhledávání: '"S. Bouju"'
Publikováno v:
European Psychiatry, Vol 64, Pp S692-S693 (2021)
Introduction Esketamine nasal spray has been developed for patients with treatment resistant depression. Objectives A cohort Temporary Authorization for Use (ATUc) allowed to collect for a 6-month period the first data in real life Methods On 02/
Externí odkaz:
https://doaj.org/article/0cbc23ce6f6544beb3587a9497539799
Publikováno v:
European Psychiatry. 64:S692-S693
IntroductionEsketamine nasal spray has been developed for patients with treatment resistant depression.ObjectivesA cohort Temporary Authorization for Use (ATUc) allowed to collect for a 6-month period the first data in real lifeMethodsOn 02/08/2019 t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4b7ee5c91de7c7377c1a4f1eef5249b2
https://doi.org/10.1192/j.eurpsy.2021.1834
https://doi.org/10.1192/j.eurpsy.2021.1834
Publikováno v:
European Neuropsychopharmacology. 53:S162
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cfe8fc3c0da320129fa3eaf0dbe27571
https://doi.org/10.1016/j.euroneuro.2021.10.214
https://doi.org/10.1016/j.euroneuro.2021.10.214
Autor:
J. Boursicot-Beuzelin, Charlotte Gary, S. Bouju, Bruno Falissard, J.Y. Giordana, P. Guillon, C. Déal, E. Fakra, C. Tessier, S. Bouée, Ludovic Samalin
Publikováno v:
European Neuropsychopharmacology. 40:S261-S262
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::781cfdc01ed3b02642edfd65182e7fd6
https://doi.org/10.1016/j.euroneuro.2020.09.340
https://doi.org/10.1016/j.euroneuro.2020.09.340
Autor:
E. Fakra, Charlotte Gary, C. Déal, P. Guillon, J.Y. Giordana, Ludovic Samalin, J. Boursicot, S. Bouju, Bruno Falissard
Publikováno v:
Revue d'Épidémiologie et de Santé Publique. 68:S83-S84
Contexte et objectifs La formulation trimestrielle de palmitate de paliperidone (PP3 M) est une option singuliere dans le traitement de maintenance de la schizophrenie [1] , [2] , [3] dont l’utilisation et l’impact en pratique clinique reste a ca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3ea77b038aff4867361cac8e0ed04883
https://doi.org/10.1016/j.respe.2020.04.040
https://doi.org/10.1016/j.respe.2020.04.040
Autor:
C. Gary, C. Déal, J. Boursicot-Beuzelin, P. Guillon, B. Falissard, J.Y. Giordana, E. Fakra, L. Samalin, S. Bouju
Publikováno v:
European Neuropsychopharmacology. 29:S456-S457
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1b78c2400b4a727fd40eb1512df50421
https://doi.org/10.1016/j.euroneuro.2019.09.645
https://doi.org/10.1016/j.euroneuro.2019.09.645
Publikováno v:
European Neuropsychopharmacology. 29:S419-S420
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7a6a26b01d4a3eb31a8c2b8d10e09feb
https://doi.org/10.1016/j.euroneuro.2018.11.636
https://doi.org/10.1016/j.euroneuro.2018.11.636
Publikováno v:
French Journal of Psychiatry. 1:S170-S171
Contexte En schizophrenie, la remission fonctionnelle traduit la capacite des patients a s’adapter aux difficultes de la vie en societe et a se reinserer dans leur environnement. Objectif Evaluer la proportion de patients obtenant une remission fon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9a9475ac84738c94a57f8cf516c0ba4f
https://doi.org/10.1016/s2590-2415(19)30433-7
https://doi.org/10.1016/s2590-2415(19)30433-7
Autor:
J. Boursicot-Beuzelin, Charlotte Gary, J.Y. Giordana, P. Guillon, S. Bouju, Bruno Falissard, Ludovic Samalin, C. Déal, E. Fakra
Publikováno v:
French Journal of Psychiatry. 1:S180
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::963a29cca25054fa08783080be5b4407
https://doi.org/10.1016/j.fjpsy.2019.10.481
https://doi.org/10.1016/j.fjpsy.2019.10.481
Autor:
Catherine Delva, S. Bouju, Cécile Deal, Charlotte Gary, Pierre-Michel Llorca, Philip Gorwood, Sylvie Lancrenon
Publikováno v:
Psychiatry Research
Psychiatry Research, Elsevier, 2019, 281, pp.112560-. ⟨10.1016/j.psychres.2019.112560⟩
Psychiatry Research, Elsevier, 2019, 281, pp.112560-. ⟨10.1016/j.psychres.2019.112560⟩
International audience; Background: Functional remission has become a major therapeutic objective in schizophrenia, but the probability of such positive outcome has a large variability, ranging from 15% to 51%. Additionally, how clinical remission co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a555d25a1799d0ec5411385bf85f059
https://doi.org/10.1016/j.psychres.2019.112560
https://doi.org/10.1016/j.psychres.2019.112560